We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CME Group (CME) Q1 Earnings and Revenues Beat Estimates
Read MoreHide Full Article
CME Group (CME - Free Report) reported first-quarter 2022 adjusted earnings per share of $2.11, which beat the Zacks Consensus Estimate of $2.00. The bottom line increased 17.9% year over year due to higher clearing and transaction fees and market data and information services.
Average daily volume increased in five out of the six products lines.
Shares gained 0.3% in the pre-market trading session to reflect the outperformance.
CME Group’s revenues of $1.3 billion increased 5% year over year. The year-over-year increase was primarily due to higher clearing and transaction fees (up 13% year over year) and market data and information services (up 5.2% year over year). The top line beat the Zacks Consensus Estimate by 5%.
Total expenses decreased 7.7% year over year to $487.5 million quarter, attributable to lower compensation and benefits, technology, professional fees and outside services, depreciation and amortization and amortization of purchased intangibles.
Operating income increased 18.5% from the prior-year quarter to $859.1 million.
ADV was 25.9 million contracts, including non-U.S. ADV of 7.3 million contracts, led by 28% growth in Latin America, 22% in Asia and 17% in EMEA.
Financial Update
As of Mar 31, 2022, CME Group had $2.9 billion of cash and marketable securities, down 26.9% from 2021 end. As of Mar 31, 2022, long-term debt of $3.4 billion increased 27.5% from 2021 end.
As of Mar 31, 2022, CME had total equity worth $27.7 billion, up 1.2% from 2021 end.
Capital Deployment
CME Group paid $1.5 billion in dividends, taking the tally to $18 billion returned to shareholders in the form of dividends since the implementation of the variable dividend policy in early 2012.
Of the industry players that have reported first-quarter results so far, Nasdaq Inc. (NDAQ - Free Report) and MarketAxess Holdings (MKTX - Free Report) beat the respective Zacks Consensus Estimate for earnings
Nasdaq’s adjusted earnings per share of $1.97 beat the Zacks Consensus Estimate by 2.1% and improved 0.5% year over year. Revenues of $892 million increased 5% year over year and matched the consensus estimate. The operating margin of 51% contracted 200 basis points year over year.
Nasdaq expects 2022 non-GAAP operating expenses in the range of $1.70 billion to $1.76 billion, narrower than the prior expectation of $1.68 billion to $1.76 billion.
MarketAxess’ earnings per share of $1.73 beat the Zacks Consensus Estimate by 1.8%, driven by revenues and trading volumes but declined from $2.11 per share a year ago. Total revenues were $186 million, reflecting a decrease of 4.6% year over year but matching the consensus estimate. The operating margin of 47% expanded 340 basis points year over year.
MarketAxess’ emerging markets volume decreased 7% year over year while emerging markets ADV was up 5%. The total credit category’s trading volumes decreased 3% year over year to $12 billion.
Upcoming Release
Intercontinental Exchange Inc. (ICE - Free Report) is scheduled to release first-quarter 2022 earnings on May 5. The Zacks Consensus Estimate for Intercontinental Exchange’s first-quarter earnings is pegged at $1.42, indicating an increase of 6% from the year-ago reported figure.
Intercontinental Exchange beat estimates in all quarters of 2021.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
CME Group (CME) Q1 Earnings and Revenues Beat Estimates
CME Group (CME - Free Report) reported first-quarter 2022 adjusted earnings per share of $2.11, which beat the Zacks Consensus Estimate of $2.00. The bottom line increased 17.9% year over year due to higher clearing and transaction fees and market data and information services.
Average daily volume increased in five out of the six products lines.
Shares gained 0.3% in the pre-market trading session to reflect the outperformance.
CME Group Inc. Price, Consensus and EPS Surprise
CME Group Inc. price-consensus-eps-surprise-chart | CME Group Inc. Quote
Performance in Detail
CME Group’s revenues of $1.3 billion increased 5% year over year. The year-over-year increase was primarily due to higher clearing and transaction fees (up 13% year over year) and market data and information services (up 5.2% year over year). The top line beat the Zacks Consensus Estimate by 5%.
Total expenses decreased 7.7% year over year to $487.5 million quarter, attributable to lower compensation and benefits, technology, professional fees and outside services, depreciation and amortization and amortization of purchased intangibles.
Operating income increased 18.5% from the prior-year quarter to $859.1 million.
ADV was 25.9 million contracts, including non-U.S. ADV of 7.3 million contracts, led by 28% growth in Latin America, 22% in Asia and 17% in EMEA.
Financial Update
As of Mar 31, 2022, CME Group had $2.9 billion of cash and marketable securities, down 26.9% from 2021 end. As of Mar 31, 2022, long-term debt of $3.4 billion increased 27.5% from 2021 end.
As of Mar 31, 2022, CME had total equity worth $27.7 billion, up 1.2% from 2021 end.
Capital Deployment
CME Group paid $1.5 billion in dividends, taking the tally to $18 billion returned to shareholders in the form of dividends since the implementation of the variable dividend policy in early 2012.
Zacks Rank
CME currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Performance of Other Industry Players
Of the industry players that have reported first-quarter results so far, Nasdaq Inc. (NDAQ - Free Report) and MarketAxess Holdings (MKTX - Free Report) beat the respective Zacks Consensus Estimate for earnings
Nasdaq’s adjusted earnings per share of $1.97 beat the Zacks Consensus Estimate by 2.1% and improved 0.5% year over year. Revenues of $892 million increased 5% year over year and matched the consensus estimate. The operating margin of 51% contracted 200 basis points year over year.
Nasdaq expects 2022 non-GAAP operating expenses in the range of $1.70 billion to $1.76 billion, narrower than the prior expectation of $1.68 billion to $1.76 billion.
MarketAxess’ earnings per share of $1.73 beat the Zacks Consensus Estimate by 1.8%, driven by revenues and trading volumes but declined from $2.11 per share a year ago. Total revenues were $186 million, reflecting a decrease of 4.6% year over year but matching the consensus estimate. The operating margin of 47% expanded 340 basis points year over year.
MarketAxess’ emerging markets volume decreased 7% year over year while emerging markets ADV was up 5%. The total credit category’s trading volumes decreased 3% year over year to $12 billion.
Upcoming Release
Intercontinental Exchange Inc. (ICE - Free Report) is scheduled to release first-quarter 2022 earnings on May 5. The Zacks Consensus Estimate for Intercontinental Exchange’s first-quarter earnings is pegged at $1.42, indicating an increase of 6% from the year-ago reported figure.
Intercontinental Exchange beat estimates in all quarters of 2021.